USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Boehringer Ingelheim International GmbH

USPTO PatentsView assignee record - 662 granted patents across 61 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

RSS updates for this company

The verdict

According to USPTO PatentsView, Boehringer ranks #678 of 49,997 tracked US assignees by granted-patent volume, with 662 patents across 61 technology areas.

#678
of 49,997 US assignees by volume
Top 2%
by Innovation Score (63.6/100)
17.1
avg claims per patent
-44%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R678 · Foreign Corporation #678 · 662 grants

GRANTS-MID · TOP-DECILE · PHOTO-FINISH · CPC-WIDE · INNOV-STRONG · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

  • GRANTS-MID 662 grants
  • TOP-DECILE #678/49,997
  • PHOTO-FINISH Datang Mobile…
  • CPC-WIDE A61P · 61 areas
  • INNOV-STRONG 63.6/100
  • CLAIMS-RICH 17.1 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -44% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Datang Mobile Communications Equipment Co., Ltd. (±1 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Boehringer

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Boehringer's Innovation Score is 63.6/100 (top 2% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

How Boehringer's grant cadence moved

Between 2020–2024, Boehringer Ingelheim International GmbH received 224 grants versus 402 in 2015–2019 (-44% equal-window velocity, below median growth). Across complete PatentsView years, output peaked in 2015 at 148 grants and bottomed in 2022 at 35. Lead class A61P accounts for 70.7% of the portfolio across 61 subclasses. Volume neighbours: Socionext Inc. (#674) and Pfizer Inc. (#682).

Boehringer's three-year grant acceleration

From 2019–2021 to 2022–2024, Boehringer Ingelheim International GmbH moved from 148 to 131 grants (0.89x the prior three-year total, a multiple, not a CAGR). Among 3,296 tracked assignees with ≥100 grants and ≥20 prior-period grants, that multiple ranks #1,532. See the growth leaderboard.

Who files at Boehringer's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Boehringer holds 662 patents at rank #678, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Boehringer

By rank, the assignees closest to #678 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Boehringer's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Boehringer, neither rank-band nor same-CPC leaders (those blocks stay above).

Boehringer's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

64 Top 2% higher than 98% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

050100150200 20152016201720182019202020212022202320242025 36
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Boehringer Ingelheim International GmbH patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 148 22.4%
2016 85 12.8%
2017 53 8.0%
2018 61 9.2%
2019 55 8.3%
2020 48 7.3%
2021 45 6.8%
2022 35 5.3%
2023 41 6.2%
2024 55 8.3%
2025partial year 36 5.4%

Which technologies does Boehringer Ingelheim International GmbH patent most?

Top 15 of 61 technology areas

Where it ranks

Overall rank by patents

#678

of 49,997 tracked assignees

Innovation Score

63.6 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Boehringer Ingelheim International GmbH's patent record in context - here's where to go next.

  • Boehringer Ingelheim International GmbH's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 70.7% of its portfolio - see every assignee active in that class. Explore A61P
  • Ranked #678 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Boehringer Ingelheim International GmbH against Socionext Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 63.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.